Expression Vectors Market by Host Type, Application, End User - Forecast to 2020

The expression vectors market is expected to reach $317.1 million by 2020 from $242.7 million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. The market is categorized on the basis of host type, application, end user, and region. The application market includes therapeutic, research, and industrial applications. The therapeutic applications segment is expected to grow at the highest CAGR in the coming five years.

Major factors contributing to the growth of the global expression vectors market include increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. For instance, in September 2014, AbCelex Technologies Inc., a privately held Canadian biotechnology company, received a venture capital fund of $1 million by Pinetree Capital Corporation for development of the company’s protein expression systems and antibody engineering techniques. Funding for protein research helps the expression vectors market to grow as it is an integral component of it.

The Asian expression vectors market is the fastest-growing market, globally. With huge man power and cost-effective manufacturing facilities, several market players are focusing on expanding their presence in the Asian countries. For instance, in November 2012, Promega Corporation (U.S.), a provider of expression vectors, opened a new facility in Shanghai, Shanghai Promega Life Science Center. This facility manufactures biological and chemical regents and instruments used in life science research and molecular diagnostics. Establishment of such facilities helps the local market with easy product availability and services.

Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the expression vectors market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on the product portfolios of the top players in the expression vectors market. The report analyzes this market by host type, application, end user, and region
‧ Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the expression vectors market
‧ Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the expression vectors market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various expression vector products across regions
‧ Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the expression vectors market

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKET SEGMENTATION 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 MARKET STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 MARKET SIZE ESTIMATION 19
2.2 MARKET BREAKDOWN & DATA TRIANGULATION 22
2.3 KEY DATA FROM SECONDARY SOURCES 23
2.4 KEY DATA FROM PRIMARY SOURCES 23
2.5 KEY INDUSTRY INSIGHTS 24
2.6 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29
4.1 EXPRESSION VECTORS MARKET, BY HOST TYPE 29
4.2 EXPRESSION VECTORS MARKET, BY APPLICATION 31
4.3 EXPRESSION VECTORS MARKET, BY END USERS 32
4.4 EXPRESSION VECTORS MARKET, BY REGION 33
5 MARKET OVERVIEW 34
5.1 INTRODUCTION 35
5.1.1 BY HOST TYPE 35
5.1.2 BY APPLICATION 35
5.1.3 BY END USER 36
5.1.4 BY REGION 36
5.2 MARKET DYNAMICS 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 High prevalence rate of lifestyle diseases, infectious diseases, and genetic disorders 38
5.2.1.2 Increase in demand for protein-based therapeutic agents 38
5.2.1.3 Funding for protein research 38
?
5.2.2 MARKET RESTRAINT 39
5.2.2.1 High cost of protein therapy 39
5.2.3 OPPORTUNITY 40
5.2.3.1 Developing countries 40
5.2.4 CHALLENGE 40
5.2.4.1 Sequestration cuts in the U.S. 40
6 EXPRESSION VECTORS MARKET, BY HOST TYPE 41
6.1 INTRODUCTION 42
6.2 BACTERIAL EXPRESSION VECTORS 43
6.2.1 E.COLI EXPRESSION VECTORS 44
6.2.2 OTHER BACTERIAL EXPRESSION VECTORS 45
6.3 MAMMALIAN EXPRESSION VECTORS 47
6.3.1 CHO EXPRESSION VECTORS 49
6.3.2 OTHER MAMMALIAN EXPRESSION VECTORS 50
6.4 INSECT EXPRESSION VECTORS 51
6.4.1 BACULOVIRUS EXPRESSION VECTORS 52
6.4.2 OTHER INSECT EXPRESSION VECTORS 53
6.5 YEAST EXPRESSION VECTORS 54
6.5.1 K. LACTIS EXPRESSION VECTORS 56
6.5.2 PICHIA PASTORIS EXPRESSION VECTORS 57
6.5.3 SACCHAROMYCES CEREVISIAE EXPRESSION VECTORS 58
6.5.4 OTHER YEAST EXPRESSION VECTORS 59
6.6 OTHER EXPRESSION VECTORS 61
7 EXPRESSION VECTORS MARKET, BY APPLICATION 62
7.1 INTRODUCTION 63
7.2 THERAPEUTIC APPLICATIONS 64
7.3 INDUSTRIAL APPLICATIONS 66
7.4 RESEARCH APPLICATIONS 68
8 EXPRESSION VECTORS MARKET, BY END USER 70
8.1 INTRODUCTION 71
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 73
8.3 CROS AND CMOS 74
8.4 ACADEMIC RESEARCH INSTITUTES 76
8.5 OTHER END USERS 77
9 GLOBAL EXPRESSION VECTORS MARKET, BY REGION 79
9.1 INTRODUCTION 80
9.2 NORTH AMERICA 81
9.2.1 U.S. 86
9.2.2 CANADA 89
9.3 EUROPE 92
9.4 ASIA 97
9.5 REST OF THE WORLD (ROW) 101
10 COMPETITIVE LANDSCAPE 106
10.1 OVERVIEW 106
10.2 MARKET SHARE ANALYSIS 107
10.3 COMPETITIVE SITUATION AND TRENDS 108
10.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 109
10.3.2 EXPANSIONS 111
10.3.3 ACQUISITIONS 111
10.3.4 NEW PRODUCT LAUNCHES 112
11 COMPANY PROFILES 113
11.1 INTRODUCTION 113
11.2 MERCK MILLIPORE (A SUBSIDIARY OF MERCK KGAA) 114
11.2.1 BUSINESS OVERVIEW 114
11.2.2 PRODUCT OFFERINGS 115
11.2.3 RECENT DEVELOPMENTS 115
11.2.4 MNM VIEW 115
11.3 THERMO FISHER SCIENTIFIC, INC. 116
11.3.1 BUSINESS OVERVIEW 116
11.3.2 PRODUCT OFFERINGS 117
11.3.3 RECENT DEVELOPMENTS 117
11.3.4 MNM VIEW 117
11.4 SIGMA-ALDRICH CORPORATION 118
11.4.1 BUSINESS OVERVIEW 118
11.4.2 PRODUCT OFFERINGS 118
11.4.3 RECENT DEVELOPMENTS 119
11.4.4 MNM VIEW 119
11.5 PROMEGA CORPORATION 120
11.5.1 BUSINESS OVERVIEW 120
11.5.2 PRODUCT OFFERINGS 120
11.5.3 RECENT DEVELOPMENTS 120
11.5.4 MNM VIEW 120
11.6 CLONTECH LABORATORIES, INC. 121
11.6.1 BUSINESS OVERVIEW 121
11.6.2 PRODUCT OFFERINGS 122
11.6.3 RECENT DEVELOPMENTS 123
11.6.4 MNM VIEW 123
?
11.7 AGILENT TECHNOLOGIES 124
11.7.1 BUSINESS OVERVIEW 124
11.7.2 PRODUCT OFFERINGS 125
11.7.3 RECENT DEVELOPMENTS 125
11.8 BIO-RAD LABORATORIES, INC. 126
11.8.1 BUSINESS OVERVIEW 126
11.8.2 PRODUCT OFFERINGS 127
11.8.3 RECENT DEVELOPMENTS 127
11.9 DNA2.0, INC. 128
11.9.1 BUSINESS OVERVIEW 128
11.9.2 PRODUCT OFFERINGS 128
11.9.3 RECENT DEVELOPMENTS 129
11.10 NEW ENGLAND BIOLABS (NEB) 130
11.10.1 BUSINESS OVERVIEW 130
11.10.2 PRODUCT OFFERINGS 130
11.10.3 RECENT DEVELOPMENTS 130
11.11 QIAGEN 131
11.11.1 BUSINESS OVERVIEW 131
11.11.2 PRODUCT OFFERINGS 132
11.11.3 RECENT DEVELOPMENTS 132
12 APPENDIX 133
12.1 INSIGHTS FROM INDUSTRY EXPERTS 133
12.2 DISCUSSION GUIDE 134
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 136
12.4 AVAILABLE CUSTOMIZATIONS 136
12.5 RELATED REPORTS 137